Literature DB >> 20650356

Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs health care system 2002 to 2006.

Paul A Heidenreich1, Anju Sahay, John R Kapoor, Michael X Pham, Barry Massie.   

Abstract

OBJECTIVES: This study sought to determine recent trends over time in heart failure hospitalization, patient characteristics, treatment, rehospitalization, and mortality within the Veterans Affairs health care system.
BACKGROUND: Use of recommended therapies for heart failure has increased in the U.S. However, it is unclear to what extent hospitalization rates and the associated mortality have improved.
METHODS: We compared rates of hospitalization for heart failure, 30-day rehospitalization for heart failure, and 30-day mortality following discharge from 2002 to 2006 in the Veterans Affairs Health Care System. Odds ratios for outcome were adjusted for patient diagnoses within the past year, laboratory data, and for clustering of patients within hospitals.
RESULTS: We identified 50,125 patients with a first hospitalization for heart failure from 2002 to 2006. Mean age did not change (70 years), but increases were noted for most comorbidities (mean Charlson score increased from 1.72 to 1.89, p < 0.0001). Heart failure admission rates remained constant at about 5 per 1,000 veterans. Mortality at 30 days decreased (7.1% to 5.0%, p < 0.0001), whereas rehospitalization for heart failure at 30 days increased (5.6% to 6.1%, p = 0.11). After adjustment for patient characteristics, the odds ratio for rehospitalization in 2006 (vs. 2002) was 0.54 (95% confidence interval [CI]: 0.47 to 0.61) for mortality, but 1.21 (95% CI: 1.04 to 1.41) for heart failure rehospitalization at 30 days.
CONCLUSIONS: Recent mortality and rehospitalization rates in the Veterans Affairs Health Care System have trended in opposite directions. These results have implications for using rehospitalization as a measure of quality of care. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20650356     DOI: 10.1016/j.jacc.2010.02.053

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  38 in total

1.  The double edged sword of performance measurement.

Authors:  Kenneth W Kizer; Susan R Kirsh
Journal:  J Gen Intern Med       Date:  2012-04       Impact factor: 5.128

2.  Impact of prior admissions on 30-day readmissions in medicare heart failure inpatients.

Authors:  Scott L Hummel; Prashanth Katrapati; Brenda W Gillespie; Anthony C Defranco; Todd M Koelling
Journal:  Mayo Clin Proc       Date:  2014-03-29       Impact factor: 7.616

3.  Length of hospital stay and its impact on subsequent early readmission in patients with acute heart failure: a report from the WET-HF Registry.

Authors:  Hidenori Moriyama; Takashi Kohno; Shun Kohsaka; Yasuyuki Shiraishi; Ryoma Fukuoka; Yuji Nagatomo; Ayumi Goda; Atsushi Mizuno; Keiichi Fukuda; Tsutomu Yoshikawa
Journal:  Heart Vessels       Date:  2019-05-27       Impact factor: 2.037

Review 4.  The Hospital Readmissions Reduction Program-learning from failure of a healthcare policy.

Authors:  Ankur Gupta; Gregg C Fonarow
Journal:  Eur J Heart Fail       Date:  2018-05-23       Impact factor: 15.534

5.  Risk stratification for death and all-cause hospitalization in heart failure clinic outpatients.

Authors:  Scott L Hummel; Hussam H Ghalib; David Ratz; Todd M Koelling
Journal:  Am Heart J       Date:  2013-10-07       Impact factor: 4.749

6.  Comparing unmet needs between community-based palliative care patients with heart failure and patients with cancer.

Authors:  Dio Kavalieratos; Arif H Kamal; Amy P Abernethy; Andrea K Biddle; Timothy S Carey; Sandesh Dev; Bryce B Reeve; Morris Weinberger
Journal:  J Palliat Med       Date:  2014-03-03       Impact factor: 2.947

7.  International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial.

Authors:  Robert J Mentz; Gad Cotter; John G F Cleland; Susanna R Stevens; Karen Chiswell; Beth A Davison; John R Teerlink; Marco Metra; Adriaan A Voors; Liliana Grinfeld; Mikhail Ruda; Viacheslav Mareev; Chaim Lotan; Daniel M Bloomfield; Mona Fiuzat; Michael M Givertz; Piotr Ponikowski; Barry M Massie; Christopher M O'Connor
Journal:  Eur J Heart Fail       Date:  2014-04-25       Impact factor: 15.534

8.  Prognostic value of increased carbohydrate antigen in patients with heart failure.

Authors:  Ana B Méndez; Jordi Ordoñez-Llanos; Andreu Ferrero; Mariana Noguero; Teresa Mir; Josefina Mora; Antoni Bayes-Genis; Sònia Mirabet; Juan Cinca; Eulàlia Roig
Journal:  World J Cardiol       Date:  2014-04-26

9.  Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST).

Authors:  Linda G Jones; Mo-Kyung Sin; Fadi G Hage; Raya E Kheirbek; Charity J Morgan; Michael R Zile; Wen-Chih Wu; Prakash Deedwania; Gregg C Fonarow; Wilbert S Aronow; Sumanth D Prabhu; Ross D Fletcher; Ali Ahmed; Richard M Allman
Journal:  Circ Heart Fail       Date:  2014-12-05       Impact factor: 8.790

10.  Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure.

Authors:  Larry A Allen; Karen E Smoyer Tomic; David M Smith; Kathleen L Wilson; Irene Agodoa
Journal:  Circ Heart Fail       Date:  2012-10-16       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.